Genomic/Plasmid Dna and Rna)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Improving DNA Plasmid Production in Escherichia Coli
Improving DNA Plasmid Production in Escherichia Coli by ADAM SINGER (Under the Direction of Mark A. Eiteman) ABSTRACT The ability to produce large quantities of plasmid DNA is imperative for wide scale availability of DNA vaccines. Large scale, high yield production relies on the synergy between host strain, plasmid, medium and production scheme. Screening as many variables as quickly and cost effectively as possible is the goal. In this study, Escherichia coli strains were transformed with two plasmids and screened for plasmid yield in shake flasks in chemically defined medium supplemented with either glucose or glycerol. High yield candidates were grown in feed batch fermentations at two specific growth rates, µ = 0.14 h-1 and µ = 0.24 h-1. As predicted, high production in shake flasks was predictive of high production in fermentations. Using our media and process, we were able to reach volumetric yields of approximately 600 mg/L and specific yields of approximately 17.82 mg/g, regardless of growth rate. We were also able to increase productivity (mg/Lh) over 30%. INDEX WORDS: E. coli, fed-batch, gene therapy, plasmid production Improving DNA Plasmid Production in Escherichia Coli by ADAM SINGER B.S., Biological Engineering, University of Georgia, 1998 A Thesis Submitted to the Graduate Faculty of The University of Georgia in Partial Fulfillment of the Requirements for the Degree MASTER OF SCIENCE ATHENS, GEORGIA 2007 © 2007 Adam Singer All Rights Reserved Improving DNA Plasmid Production in Escherichia Coli by ADAM SINGER Major Professor: Mark A. Eiteman Committee: Elliot Altman Sidney Kushner Electronic Version Approved: Maureen Grasso Dean of the Graduate School The University of Georgia August 2007 iv DEDICATION To my wife Dana and my daughter Sydney-Rose. -
Synthesis of a Contiguous 32-Kb Polyketide Synthase Gene Cluster
Total synthesis of long DNA sequences: Synthesis of a contiguous 32-kb polyketide synthase gene cluster Sarah J. Kodumal, Kedar G. Patel, Ralph Reid, Hugo G. Menzella, Mark Welch, and Daniel V. Santi* Kosan Biosciences, Inc., 3832 Bay Center Place, Hayward, CA 94545 Communicated by Robert M. Stroud, University of California, San Francisco, CA, September 17, 2004 (received for review July 19, 2004) To exploit the huge potential of whole-genome sequence infor- Our efforts to this end stemmed from a desire to develop mation, the ability to efficiently synthesize long, accurate DNA heterologous expression of large polyketide synthase (PKS) sequences is becoming increasingly important. An approach pro- genes in Escherichia coli. Type I modular PKS genes encode the posed toward this end involves the synthesis of Ϸ5-kb segments of giant enzymes (among the largest proteins known) that synthe- DNA, followed by their assembly into longer sequences by con- size polyketide natural products such as erythromycin, epothi- ventional cloning methods [Smith, H. O., Hutchinson, C. A., III, lone, and tacrolimus (12). These genes reside within the high Pfannkoch, C. & Venter, J. C. (2003) Proc. Natl. Acad. Sci. USA 100, GϩC genomes of the actinomycete and myxobacterial groups of 15440–15445]. The major current impediment to the success of this prokaryotes and encode proteins with multiple sets, or modules, tactic is the difficulty of building the Ϸ5-kb components accurately, of active sites (domains). Each module catalyzes the assembly of efficiently, and rapidly from short synthetic oligonucleotide build- a specific two-carbon-unit component of the polyketide product. ing blocks. -
Expression Cloning of a Human Dual-Specificity Phosphatase TOSHIO ISHIBASHI, DONALD P
Proc. Nati. Acad. Sci. USA Vol. 89, pp. 12170-12174, December 1992 Biochemistry Expression cloning of a human dual-specificity phosphatase TOSHIO ISHIBASHI, DONALD P. BOTTARO, ANDREW CHAN, TORU MIKI, AND STUART A. AARONSON* Laboratory of Cellular and Molecular Biology, National Cancer Institute, Bethesda, MD 20892 Communicated by Leon A. Heppel, September 24, 1992 ABSTRACT Using an expression cloning strategy, we iso- substrate specificity for both phosphotyrosine and phospho- lated a cDNA encoding a human protein-tyrosine-phosphatase. serine. Bacteria expressing the kinase domain of the keratinocyte growth factor receptor (bek/fibroblast growth factor receptor 2) were infected with a fibroblast cDNA library in a phanid MATERIALS AND METHODS prokaryotic expression vector and screened with a monoclonal Plamid Construction of bek Kiame. The EcoRI-Sal I anti-phosphotyrosine antibody. Among several clones showing fragment of the mouse keratinocyte growth factor (KGF) decreased anti-phosphotyrosine recognition, one displayed receptor cDNA (15), which includes the kinase and carboxyl- phosphatase activity toward the kinase in vitro. The 4.1- terminal domains (residues 361-707), was ligated to the kilobase cDNA encoded a deduced protein of 185 amino ds EcoRP-Sal I fragment ofthe expression vector pCEV-lacZ to with limited sequence similar to the vaccinia virus phospha- generate the plasmid pCEV-bek (Fig. 1A). pCEV-lacZ is a tase VH1. The puriffied recombinant protein dephosphorlated pUC-based plasmid expression vector that produces a 3-gal several activated growth factor receptors, as well as serine- fusion protein under the control of the lac promoter (see phosphorylated casein, in vitro. Both serine and tyrosine phos- below). -
US5266490.Pdf
||||||||||||I|| US005266490A United States Patent (19) 11 Patent Number: 5,266,490 Davis et al. 45 Date of Patent: Nov.30, 1993 (54) MAMMALIAN EXPRESSION VECTOR Maniatis et al. (1990), Molecular Cloning: A Laboratory Manual, vol. 2, pp. 16.3-16.81. 75 Inventors: Samuel Davis, New York; George D. Martson (1987), DNA Cloning: A Practical Approach, Yancopoulos, Briarcliff Manor, both vol. 3, Chap. 4, pp. 59-88. of N.Y. Mizushima et al. (1990), Nucl. Acids Res. 18 (17): 5322. 73) Assignee: Regeneron Pharmaceuticals, Inc., Sambrook et al. (1988), Focus 10(3): 41-48. Tarrytown, N.Y. Simmons et al. (1988), J. Immunol. 141 (8): 2797-2800. Spector (1985), Genet. Engineering 7: 199-234. (21) Appl. No.: 678,408 Stamenkovic et al. (1988), J. Exp. Med. 167: 1975-1980. (22 Filed: Mar. 28, 1991 Urlaub et al. (1980), Proc. Nat. Acad. Sci USA 77(7): 51) Int. Cl.5...................... C12N 15/79; C12N 15/12; 426-4220. C12N 15/18 Woeltje et al. (1990), J. Biol. Chem. 265 (18): 10720-10725. 52) U.S. C. ................................ 435/320.1; 536/23.4; Wysocki et al. (1978); Proc. Nat. Acad. Sci USA 75(6): 536/23.5; 536/24.1 2844-2848. 58) Field of Search ................. 435/320.1, 69.1, 172.3; Seed, B. (Oct. 1987), Nature, vol. 329, pp. 840-842. 536/27, 24.1, 23.4, 23.5 Yanisch-Perron et al. (1985), Gene, vol. 33, pp. (56) References Cited 103-119. PUBLICATIONS Seed et al. (May, 1987), Proc. Nat. Acad. Sci USA, vol. 84, pp. 3365-3369. -
Temporal Proteomic Analysis of HIV Infection Reveals Remodelling of The
1 1 Temporal proteomic analysis of HIV infection reveals 2 remodelling of the host phosphoproteome 3 by lentiviral Vif variants 4 5 Edward JD Greenwood 1,2,*, Nicholas J Matheson1,2,*, Kim Wals1, Dick JH van den Boomen1, 6 Robin Antrobus1, James C Williamson1, Paul J Lehner1,* 7 1. Cambridge Institute for Medical Research, Department of Medicine, University of 8 Cambridge, Cambridge, CB2 0XY, UK. 9 2. These authors contributed equally to this work. 10 *Correspondence: [email protected]; [email protected]; [email protected] 11 12 Abstract 13 Viruses manipulate host factors to enhance their replication and evade cellular restriction. 14 We used multiplex tandem mass tag (TMT)-based whole cell proteomics to perform a 15 comprehensive time course analysis of >6,500 viral and cellular proteins during HIV 16 infection. To enable specific functional predictions, we categorized cellular proteins regulated 17 by HIV according to their patterns of temporal expression. We focussed on proteins depleted 18 with similar kinetics to APOBEC3C, and found the viral accessory protein Vif to be 19 necessary and sufficient for CUL5-dependent proteasomal degradation of all members of the 20 B56 family of regulatory subunits of the key cellular phosphatase PP2A (PPP2R5A-E). 21 Quantitative phosphoproteomic analysis of HIV-infected cells confirmed Vif-dependent 22 hyperphosphorylation of >200 cellular proteins, particularly substrates of the aurora kinases. 23 The ability of Vif to target PPP2R5 subunits is found in primate and non-primate lentiviral 2 24 lineages, and remodeling of the cellular phosphoproteome is therefore a second ancient and 25 conserved Vif function. -
A Visual Demonstration of Plasmid DNA Preparation from Bacteria
HOW-TO-'DO-IT A Visual Demonstration of Plasmid DNA Preparation from Bacteria * RALPH L. KEIL, LAURA K. PALMER Downloaded from http://online.ucpress.edu/abt/article-pdf/71/6/363/55200/20565332.pdf by guest on 02 October 2021 Unprecedented advances in unraveling mysteries of life have disease, or other areas the students or instructor want to develop. occurred as a result of the molecular biology revolution. Some Since many students know someone with diabetes (in many cases major achievements of this revolution include new methods for the they know a classmate who has diabetes or one of them may even production of therapeutic compounds, insights into mechanisms suffer from the disease), this example provides an opportunity to of gene function and regulation, and the complete sequencing of get students to actively participate in discussion, regardless of their the genomes of numerous organisms including humans. A critical academic abilities. foundation of this revolution is the ability to use the bacterium An alternative introduction is to discuss consequences of Escherichia coli (E. coli) as a factory to produce large amounts of sequencing the entire three billion base pairs of DNA of the virtually any DNA of interest by inserting it into a small, extrachro human genome (http://www.ornl.gov/sci/techresources/Human mosomal circle of DNA called a plasmid. The ease and reproducibil Genome/home.shtml). The current and potential uses of this ity of plasmid DNA isolation from bacteria permits numerous labs technology in forensic science, health care, and business decisions to conduct molecular biology experiments and greatly accelerates are all areas that may be discussed depending on what focus the progress in understanding complex biological processes. -
Control of Ph During Plasmid Preparation by Alkaline Lysis of Escherichia Coli
Analytical Biochemistry 378 (2008) 224–225 Contents lists available at ScienceDirect Analytical Biochemistry journal homepage: www.elsevier.com/locate/yabio Notes & Tips Control of pH during plasmid preparation by alkaline lysis of Escherichia coli Cheri Cloninger, Marilyn Felton 1, Bonnie Paul 1, Yasuko Hirakawa, Stan Metzenberg * Department of Biology, California State University, Northridge, Northridge, CA 91330, USA article info abstract Article history: Alkaline lysis of Escherichia coli is usually the method of choice for plasmid preparation, but ‘‘ghost bands” Received 9 March 2008 of denatured supercoiled DNA can result if the pH is too high or the period of lysis is too long. By replacing Available online 11 April 2008 the usual sodium hydroxide lysis solution with an arginine buffer prepared in the range of pH 11.4 to 12.0, we were able to stabilize the pH during lysis and obtain plasmid that is suitably pure for restriction digestion and DNA sequencing. Ó 2008 Elsevier Inc. All rights reserved. The extraction of plasmids from Escherichia coli is one of the most 2. To each 1 ml of cell suspension, 1 ml of a lysis solution consist- commonly used methods in molecular biology, and detergent lysis of ing of 1% (w/v) sodium dodecyl sulfate (SDS) and 0.5 M L-argi- cells in 0.1 M sodium hydroxide (NaOH,2 final) is the most wide- nine (pH 11.7) is added, and the tube is capped and rocked spread approach [1,2]. The alkalinity denatures the chromosomal briefly to mix. The lysate is allowed to sit undisturbed for 5 min. -
Human Intestinal Nutrient Transporters
Gastrointestinal Functions, edited by Edgard E. Delvin and Michael J. Lentze. Nestle Nutrition Workshop Series. Pediatric Program. Vol. 46. Nestec Ltd.. Vevey/Lippincott Williams & Wilkins, Philadelphia © 2001. Human Intestinal Nutrient Transporters Ernest M. Wright Department of Physiology, UCLA School of Medicine, Los Angeles, California, USA Over the past decade, advances in molecular biology have revolutionized studies on intestinal nutrient absorption in humans. Before the advent of molecular biology, the study of nutrient absorption was largely limited to in vivo and in vitro animal model systems. This did result in the classification of the different transport systems involved, and in the development of models for nutrient transport across enterocytes (1). Nutrients are either absorbed passively or actively. Passive transport across the epithelium occurs down the nutrient's concentration gradient by simple or facilitated diffusion. The efficiency of simple diffusion depends on the lipid solubility of the nutrient in the plasma membranes—the higher the molecule's partition coefficient, the higher the rate of diffusion. Facilitated diffusion depends on the presence of simple carriers (uniporters) in the plasma membranes, and the kinetic properties of these uniporters. The rate of facilitated diffusion depends on the density, turnover number, and affinity of the uniporters in the brush border and basolateral membranes. The ' 'active'' transport of nutrients simply means that energy is provided to transport molecules across the gut against their concentration gradient. It is now well recog- nized that active nutrient transport is brought about by Na+ or H+ cotransporters (symporters) that harness the energy stored in ion gradients to drive the uphill trans- port of a solute. -
Molecular Biology Services Price List Denmark; Valid from 01.09.2017
Molecular Biology Services Price List Denmark; valid from 01.09.2017 Gene Synthesis Service Delivery times for Gene Synthesis Service: Standard Genes up to 1000 bp: 6 business days; guaranteed: 12 business days Standard Genes ≤ 3000 bp: 15 - 20 business days Standard Genes > 3000 bp: 4 additional business days/kb; Subcloning: additional 5 - 10 business days Express Genes up to 1000 bp: 4 business days Express Genes up to 1500 bp: 6 business days; up to 2000 bp: 7 days; Express Genes up to 3000 bp: 11 business days; up to 4000 bp: 13 days; Express subcloning: 4 business days Delivery time for complex gene varies. Dependent on the complexity of the gene, usually it takes 5-10 business days longer than estimated for standard genes. Part ID Service Description Price [DKK] 5001-000010 Short Standard Genes (≤ 500 bp) 1,125.00 / gene 5001-000016 Standard Genes (501-1000 bp) 2.40 / base pair 5001-000012 Long Standard Genes (1001-3000bp) 2.40 / base pair 5001-000019 Long Standard Genes (3001-4000bp) 2.70 / base pair 5001-000119 Long Standard Gene (4001-5000bp) 3.00 / base pair 5001-000219 Long Standard Gene (5001-6000bp) 3.15 / base pair 5001-000319 Long Standard Gene (6001-7000bp) 3.53 / base pair 5001-000419 Long Standard Gene (7001-8000bp) 3.53 / base pair 5001-000519 Long Standard Gene (8001-9000bp) 3.53 / base pair 5001-000619 Long Standard Gene (9001-10000bp) 3.53 / base pair 5001-000719 Long Standard Gene > 10 kb on request 5001-000021 Complex Genes on request 5001-000230 Express Fee Short Standard Gene (≤ 500 bp) 3,000.00 / gene 5001-000232 -
An Improved System for Competent Cell Preparation and High Efficiency Plasmid Transformation Using Different Escherichia Coli Strains
Electronic Journal of Biotechnology ISSN: 0717-3458 Vol.8 No.1, Issue of April 15, 2005 © 2005 by Pontificia Universidad Católica de Valparaíso -- Chile Received June 8, 2004 / Accepted January 13, 2005 TECHNICAL NOTE An improved system for competent cell preparation and high efficiency plasmid transformation using different Escherichia coli strains Zhiming Tu China-UK HUST-Res Crop Genetics Engineering and Genomics Joint Laboratory School of Life Science and Technology Huazhong University of Science and Technology Wuhan, 4300074, China Tel: 86 27 87556214 Fax: 86 27 87548885 E-mail: [email protected] Guangyuan He* China-UK HUST-RRes Crop Genetics Engineering and Genomics Joint Laboratory School of Life Science and Technology Huazhong University of Science and Technology Wuhan, 4300074, China Tel: 86 27 87556214 Fax: 85 27 87548885 E-mail: [email protected] Kexiu X. Li China-UK HUST-RRes Crop Genetics Engineering and Genomics Joint Laboratory School of Life Science and Technology Huazhong University of Science and Technology Wuhan, 4300074, China Tel: 86 27 87556214 Fax: 86 27 87548885 Mingjie J. Chen China-UK HUST-RRes Crop Genetics Engineering and Genomics Joint Laboratory School of Life Science and Technology Huazhong University of Science and Technology Wuhan, 4300074, China Tel: 86 27 87556214 Fax: 86 27 87548885 Junli Chang China-UK HUST-RRes Crop Genetics Engineering and Genomics Joint Laboratory School of Life Science and Technology Huazhong University of Science and Technology Wuhan, 4300074, China Tel: 86 27 87556214 Fax: 86 2787548885 Ling Chen China-UK HUST-RRes Crop Genetics Engineering and Genomics Joint Laboratory School of Life Science and Technology Huazhong University of Science and Technology Wuhan, 4300074, China Tel: 86 27 87556214 Fax: 86 2787548885 Qing Yao China-UK HUST-RRes Crop Genetics Engineering and Genomics Joint Laboratory School of Life Science and Technology Huazhong University of Science and Technology Wuhan, 4300074, China Tel: 86 27 87556214 Fax: 86 2787548885 Dongping P. -
Eukaryotic Expression Cloning with an Antimetastatic
[CANCER RESEARCH 59, 3812–3820, August 1, 1999] Eukaryotic Expression Cloning with an Antimetastatic Monoclonal Antibody Identifies a Tetraspanin (PETA-3/CD151) as an Effector of Human Tumor Cell Migration and Metastasis1 Jacqueline E. Testa,2,3 Peter C. Brooks,4 Jian-Min Lin,5 and James P. Quigley3 Department of Pathology, State University of New York at Stony Brook, Stony Brook, New York 11794 ABSTRACT interactions with different matrix proteins. Our efforts to identify novel metastasis-associated antigens have, therefore, focused on the tumor cell A monoclonal antibody (mAb), 50-6, generated by subtractive immuniza- surface. As our model system, we have used a highly metastatic human tion, was found to specifically inhibit in vivo metastasis of a human epider- epidermoid carcinoma cell line, HEp-3, which disseminates to host lung moid carcinoma cell line, HEp-3. The cDNA of the cognate antigen of mAb 50-6 was isolated by a modified eukaryotic expression cloning protocol from tissue. The distinct characteristics and behavior patterns of this tumor cell a HEp-3 library. Sequence analysis identified the antigen as PETA-3/CD151, line have been described by Ossowski in a series of papers published a recently described member of the tetraspanin family of proteins. The cloned between 1980 and 1998 (7–9). These cells are very aggressive and readily antigen was also recognized by a previously described antimetastatic anti- give rise to metastasizing tumors in both the chicken embryo (10–12) and body, mAb 1A5. Inhibition of HEp-3 metastasis by the mAbs could not be in the nude mouse model (13, 14). -
SGI-DNA-Bioxp-Lucigen-Webinar
Accelerate your Research with Synthetic DNA and Hands-free Cloning Brought to you in collaboration with Lucigen and SGI-DNA Introduction Julie K. Robinson Synthetic Genomics, SGI-DNA Sr. Product Manager, Synthetic Biology The Potential of Synthetic Biology C O P Y R I G H T © 2 0 1 7 S Y N T H E T I C G E N O M I C S , I N C. | 2 Synthetic Genomics Collaborative Efforts Advance C O P Y R I G H T © 2 0 1 7 S Y N T H E T I C G E N O M I C S , I N C. | 3 Advancing Genomic Research Solutions, SGI-DNA Reagents Instruments ● Gibson Assembly® enables rapid assembly ● BioXp™ 3200 – an automated, benchtop of multiple DNA fragments genomics workstation ● Vmax electrocompetent cells for protein ● Create genes, genetic elements and complex expression genetic sequences ● Uses electronically transmitted sequence to build genes Services Bioinformatics ● Synthesize custom DNA of varying size ● Expert bioinformatics support, which and complexity includes whole genome annotation, gene expression analysis, and other types of ● Utilizes patented Gibson Assembly® sequence design method and error correction technology ● Archetype® software enables ‘omics-based ● Cell engineering services understanding of data to enable researchers ● NGS and plasmid preparation services to discover, analyze and build genes C O P Y R I G H T © 2 0 1 7 S Y N T H E T I C G E N O M I C S , I N C. | 4 Common Genomic applications Applications of DNA Cloning Study of Genomes & Transgenic Gene Expression Gene Therapy Organisms Biopharmaceutical Recombinant Protein Cell Engineering Research Production C O P Y R I G H T © 2 0 1 7 S Y N T H E T I C G E N O M I C S , I N C.